AKILEINE VAPORISATEUR ANTITRANSPIRANT 50 MG
ALUMINUM CHLOROHYDRATE : 50 MG ALCOHOL ANHYDROUS : 600 MG · DIN 00611492 · LABORATOIRE LARIMA LTÉE
Health Canada status: CANCELLED POST MARKET
What is AKILEINE VAPORISATEUR ANTITRANSPIRANT?
AKILEINE VAPORISATEUR ANTITRANSPIRANT 50 MG contains ALUMINUM CHLOROHYDRATE : 50 MG ALCOHOL ANHYDROUS : 600 MG. It is listed in the Health Canada Drug Product Database under DIN 00611492, held by LABORATOIRE LARIMA LTÉE, supplied as SPRAY for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 31-Jul-2007. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00611492 |
|---|---|
| Brand name | AKILEINE VAPORISATEUR ANTITRANSPIRANT |
| Generic / active ingredient | ALUMINUM CHLOROHYDRATE : 50 MG ALCOHOL ANHYDROUS : 600 MG |
| Manufacturer | LABORATOIRE LARIMA LTÉE |
| Strength | 50 MG |
| Dosage form | SPRAY |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D11AA ANTIHIDROTICS |
| AHFS class | 84:12.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 31-Jul-2007 |
| Original market date | 1985-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code D11AA ANTIHIDROTICS. 0 of 397 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| 24 HOUR ANTIPERSPIRANT STICK 24.% | 24 % | STICK | ARAMIS, DIST. | CANCELLED POST MARKET | DIN 01990756 |
| ACTIVE ROLL-ON ANTI-PERSPIRANT DEODORANT | 17 % | LIQUID | AVALLA (CANADA) INC. | CANCELLED POST MARKET | DIN 02244570 |
| ADIDAS 24 HR PROTECTION ANTI-PERSPIRANT COOL GEL FOR MEN | 19 % | GEL | COTY CANADA INC. | CANCELLED POST MARKET | DIN 02259931 |
| ADIDAS ACTIVE ANTI-PERSPIRANT FOR WOMEN | 20 % | STICK | COTY CANADA INC. | CANCELLED POST MARKET | DIN 02248243 |
| ADIDAS ACTIVE ANTIPERSPIRANT DEODORANT | 16 % | STICK | COTY CANADA INC. | CANCELLED POST MARKET | DIN 02247294 |
| ADIDAS ANTIPERSPIRANT DEODORANT | 18.8 % | STICK | COTY CANADA INC. | CANCELLED POST MARKET | DIN 02242992 |
| AKILEINE CRM | 40 MG | CREAM | LABORATOIRE LARIMA LTÉE | CANCELLED POST MARKET | DIN 00648612 |
| ALFRED SUNG SCENTED ANTIPERSP STK 20% | 20 % | STICK | RIVIERA CONCEPTS INC. | CANCELLED POST MARKET | DIN 00784737 |
| ALYSSA ASHLEY MUSK CREME DES.A. BILLE-20 | 20.06 % | CREAM | HOUBIGANT (1995) LTÉE. | CANCELLED POST MARKET | DIN 02209683 |
| ALYSSA ASHLEY MUSK CREME DESODOR. A BILLE | 20.06 % | CREAM | PARFUMS ALYSSA ASHLEY INC. | CANCELLED POST MARKET | DIN 02034964 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.